Behavioural studies with a newly developed neuroprotective KYNA-amide. (Q48961949)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21818601%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

title

Behavioural studies with a newly developed neuroprotective KYNA-amide (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21818601%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21818601%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Levente Gellért

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21818601%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Dániel Varga

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21818601%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Zsolt Kis

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21818601%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

author name string

Marian Ruszka

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21818601%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

József Toldi

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21818601%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Tamás Farkas

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21818601%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

István Szatmári

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21818601%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Ferenc Fülöp

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21818601%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

publication date

5 August 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21818601%20AND%20SRC:MED&resulttype=core&format=json

Journal of Neural Transmission

9 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21818601%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

volume

119

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21818601%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21818601%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

page(s)

165-172

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21818601%20AND%20SRC:MED&resulttype=core&format=json

A synaptic model of memory: long-term potentiation in the hippocampus

9 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0692-8

A novel NMDA antagonist, MK-801, impairs performance in a hippocampal-dependent spatial learning task.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0692-8

Elevations of endogenous kynurenic acid produce spatial working memory deficits

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0692-8

Pathobiology of ischaemic stroke: an integrated view

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0692-8

Endogenous kynurenic acid disrupts prepulse inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0692-8

Syntheses, transformations and pharmaceutical applications of kynurenic acid derivatives

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0692-8

The acute effects of NMDA antagonism: from the rodent to the human brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0692-8

The kynurenate analog SZR-72 prevents the nitroglycerol-induced increase of c-fos immunoreactivity in the rat caudal trigeminal nucleus: comparative studies of the effects of SZR-72 and kynurenic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0692-8

A novel kynurenic acid analogue: a comparison with kynurenic acid. An in vitro electrophysiological study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0692-8

Glutamate-based therapeutic approaches: clinical trials with NMDA antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0692-8

NMDA receptors, place cells and hippocampal spatial memory

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0692-8

Blockade of hippocampal nicotinic receptors impairs working memory but not reference memory in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0692-8

Intrahippocampal administration of a glycine site antagonist impairs working memory performance of rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0692-8

Kynurenic acid has a dual action on AMPA receptor responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0692-8

Nanomolar concentrations of kynurenic acid reduce extracellular dopamine levels in the striatum

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0692-8

Selective vulnerability of the hippocampus in brain ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0692-8

Manipulation of brain kynurenines: glial targets, neuronal effects, and clinical opportunities

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0692-8

Development and therapeutic potential of kynurenic acid and kynurenine derivatives for neuroprotection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0692-8

The pharmacological manipulation of glutamate receptors and neuroprotection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0692-8

Dopamine and synaptic plasticity in dorsal striatal circuits controlling action selection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0692-8

The role of kynurenines in disorders of the central nervous system: possibilities for neuroprotection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0692-8

l-kynurenine combined with probenecid and the novel synthetic kynurenic acid derivative attenuate nitroglycerin-induced nNOS in the rat caudal trigeminal nucleus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0692-8

Intracerebroventricular injection of kynurenic acid, but not kynurenine, induces ataxia and stereotyped behavior in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0692-8

Hippocampal N-methyl-D-aspartate receptor-mediated encoding and retrieval processes in spatial working memory: delay-interposed radial maze performance in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0692-8

Kynurenines in chronic neurodegenerative disorders: future therapeutic strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0692-8

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0692-8

The brain metabolite kynurenic acid inhibits alpha7 nicotinic receptor activity and increases non-alpha7 nicotinic receptor expression: physiopathological implications

21 January 2018

1 reference

12 December 2020

Kynurenergic manipulations influence excitatory synaptic function and excitotoxic vulnerability in the rat hippocampus in vivo

1 reference

12 December 2020

Glutamate antagonists in therapy of stroke.

1 reference

12 December 2020

1 reference

12 December 2020

Reduction of endogenous kynurenic acid formation enhances extracellular glutamate, hippocampal plasticity, and cognitive behavior

1 reference

12 December 2020

Neuroprotection with a new kynurenic acid analog in the four-vessel occlusion model of ischemia

1 reference

12 December 2020

Cerebral synthesis and release of kynurenic acid: an endogenous antagonist of excitatory amino acid receptors.

1 reference

12 December 2020

10.1007/S00702-011-0692-8

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21818601%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

1 reference